These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 17968950)

  • 1. Overexpression of human decoy receptor 3 in mice results in a systemic lupus erythematosus-like syndrome.
    Han B; Moore PA; Wu J; Luo H
    Arthritis Rheum; 2007 Nov; 56(11):3748-58. PubMed ID: 17968950
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DcR3 as a diagnostic parameter and risk factor for systemic lupus erythematosus.
    Han B; Bojalil R; Amezcua-Guerra LM; Springall R; Valderrama-Carvajal H; Wu J; Luo H
    Int Immunol; 2008 Aug; 20(8):1067-75. PubMed ID: 18562337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated serum decoy receptor 3 with enhanced T cell activation in systemic lupus erythematosus.
    Lee CS; Hu CY; Tsai HF; Wu CS; Hsieh SL; Liu LC; Hsu PN
    Clin Exp Immunol; 2008 Mar; 151(3):383-90. PubMed ID: 18190609
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decoy receptor 3 ameliorates an autoimmune crescentic glomerulonephritis model in mice.
    Ka SM; Sytwu HK; Chang DM; Hsieh SL; Tsai PY; Chen A
    J Am Soc Nephrol; 2007 Sep; 18(9):2473-85. PubMed ID: 17687076
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DcR3 protects islet beta cells from apoptosis through modulating Adcyap1 and Bank1 expression.
    Han B; Wu J
    J Immunol; 2009 Dec; 183(12):8157-66. PubMed ID: 20007581
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DcR3 mutations in patients with juvenile-onset systemic lupus erythematosus lead to enhanced lymphocyte proliferation.
    Chokdeemeeboon C; Ammarinthnukrowh P; Tongkobpetch S; Srichomtong C; Deekajorndech T; Rianthavorn P; Kingwattanakul P; Avihingsanon Y; Wright HL; Akkahat P; Hoven VP; Mekboonsonglarp W; Edwards SW; Hirankarn N; Suphapeetiporn K; Shotelersuk V
    J Rheumatol; 2013 Aug; 40(8):1316-26. PubMed ID: 23729807
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decoy receptor 3 protects non-obese diabetic mice from autoimmune diabetes by regulating dendritic cell maturation and function.
    Wang YL; Chou FC; Sung HH; Fan PL; Hsueh CW; Lin WC; Chen SJ; Lin WW; Sytwu HK
    Mol Immunol; 2010 Oct; 47(16):2552-62. PubMed ID: 20801512
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decoy receptor 3 expressed in rheumatoid synovial fibroblasts protects the cells against Fas-induced apoptosis.
    Hayashi S; Miura Y; Nishiyama T; Mitani M; Tateishi K; Sakai Y; Hashiramoto A; Kurosaka M; Shiozawa S; Doita M
    Arthritis Rheum; 2007 Apr; 56(4):1067-75. PubMed ID: 17393415
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decoy receptor 3 overexpression and immunologic tolerance in hepatocellular carcinoma (HCC) development.
    Chen C; Zhang C; Zhuang G; Luo H; Su J; Yin P; Wang J
    Cancer Invest; 2008 Dec; 26(10):965-74. PubMed ID: 19093253
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transgenic overexpression of anti-double-stranded DNA autoantibody and activation of Toll-like receptor 4 in mice induce severe systemic lupus erythematosus syndromes.
    Lee TP; Tang SJ; Wu MF; Song YC; Yu CL; Sun KH
    J Autoimmun; 2010 Dec; 35(4):358-67. PubMed ID: 20833510
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Decoy Receptor 3 (DcR3, TNFRSF6B) suppresses Th17 immune responses and is abundant in human cerebrospinal fluid.
    Mueller AM; Pedré X; Killian S; David M; Steinbrecher A
    J Neuroimmunol; 2009 Apr; 209(1-2):57-64. PubMed ID: 19269042
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional characterisation of decoy receptor 3 in Crohn's disease.
    Funke B; Autschbach F; Kim S; Lasitschka F; Strauch U; Rogler G; Gdynia G; Li L; Gretz N; Macher-Goeppinger S; Sido B; Schirmacher P; Meuer SC; Roth W
    Gut; 2009 Apr; 58(4):483-91. PubMed ID: 19039087
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transgenic expression of decoy receptor 3 protects islets from spontaneous and chemical-induced autoimmune destruction in nonobese diabetic mice.
    Sung HH; Juang JH; Lin YC; Kuo CH; Hung JT; Chen A; Chang DM; Chang SY; Hsieh SL; Sytwu HK
    J Exp Med; 2004 Apr; 199(8):1143-51. PubMed ID: 15078896
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNA hypomethylation is crucial for apoptotic DNA to induce systemic lupus erythematosus-like autoimmune disease in SLE-non-susceptible mice.
    Wen ZK; Xu W; Xu L; Cao QH; Wang Y; Chu YW; Xiong SD
    Rheumatology (Oxford); 2007 Dec; 46(12):1796-803. PubMed ID: 18032537
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of systemic lupus erythematosus-like syndrome in syngeneic mice by immunization with activated lymphocyte-derived DNA.
    Qiao B; Wu J; Chu YW; Wang Y; Wang DP; Wu HS; Xiong SD
    Rheumatology (Oxford); 2005 Sep; 44(9):1108-14. PubMed ID: 15840592
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BAFF overexpression and accelerated glomerular disease in mice with an incomplete genetic predisposition to systemic lupus erythematosus.
    Stohl W; Xu D; Kim KS; Koss MN; Jorgensen TN; Deocharan B; Metzger TE; Bixler SA; Hong YS; Ambrose CM; Mackay F; Morel L; Putterman C; Kotzin BL; Kalled SL
    Arthritis Rheum; 2005 Jul; 52(7):2080-91. PubMed ID: 15986357
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of lupus-prone NZB/NZW F1 mice with recombinant soluble Fc gamma receptor II (CD32).
    Werwitzke S; Trick D; Sondermann P; Kamino K; Schlegelberger B; Kniesch K; Tiede A; Jacob U; Schmidt RE; Witte T
    Ann Rheum Dis; 2008 Feb; 67(2):154-61. PubMed ID: 17557887
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Requirement of Toll-like receptor 7 for pristane-induced production of autoantibodies and development of murine lupus nephritis.
    Savarese E; Steinberg C; Pawar RD; Reindl W; Akira S; Anders HJ; Krug A
    Arthritis Rheum; 2008 Apr; 58(4):1107-15. PubMed ID: 18383384
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decoy receptor 3 enhances tumor progression via induction of tumor-associated macrophages.
    Tai SK; Chang HC; Lan KL; Lee CT; Yang CY; Chen NJ; Chou TY; Tarng DC; Hsieh SL
    J Immunol; 2012 Mar; 188(5):2464-71. PubMed ID: 22287720
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of novel antigens recognized by serum autoantibodies from anti-CD1 TCR-transgenic lupus mice.
    Hueber W; Zeng D; Sharpe O; Robinson WH; Strober S; Utz PJ
    Eur J Immunol; 2004 Jun; 34(6):1654-62. PubMed ID: 15162435
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.